Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 12:13:2637-2658.
doi: 10.3762/bjoc.13.262. eCollection 2017.

Recent progress in the racemic and enantioselective synthesis of monofluoroalkene-based dipeptide isosteres

Affiliations
Review

Recent progress in the racemic and enantioselective synthesis of monofluoroalkene-based dipeptide isosteres

Myriam Drouin et al. Beilstein J Org Chem. .

Abstract

Monofluoroalkenes are fluorinated motifs that can be used to replace amide bonds. In order to be incorporated into peptides, it is normally necessary to first synthesize a dipeptide where the amide bond has been replaced with a monofluoroalkene. In that context, this review will present the racemic and enantioselective synthesis of monofluoroalkene-based dipeptide isosteres described since 2007. Some applications of those compounds will also be presented.

Keywords: dipeptide isosteres; monofluoroalkene-based amide bonds; monofluoroalkenes; peptides; synthesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selected amide bond isosteres.
Figure 2
Figure 2
Monofluoroalkene as an amide bond isostere.
Scheme 1
Scheme 1
Synthesis of Cbz-Gly-ψ[(Z)-CF=CH]-Gly using a HWE olefination by Sano and co-workers.
Scheme 2
Scheme 2
Synthesis of Phth-Gly-ψ[CF=CH]-Gly using the Julia–Kocienski olefination by Lequeux and co-workers.
Scheme 3
Scheme 3
Synthesis of Boc-Nva-ψ[(Z)-CF=CH]-Gly by Taguchi and co-workers.
Figure 3
Figure 3
Mutant tripeptide containing two different peptide bond isosteres.
Scheme 4
Scheme 4
Chromium-mediated synthesis of Boc-Ser(PMB)-ψ[(Z)-CF=CH]-Gly-OMe by Konno and co-workers.
Scheme 5
Scheme 5
Synthesis of Cbz-Gly-ψ[(E)-CF=C]-Pro by Sano and co-workers.
Scheme 6
Scheme 6
Synthesis of Cbz-Gly-ψ[(Z)-CF=C]-Pro by Sano and co-workers.
Scheme 7
Scheme 7
Stereoselective synthesis of Fmoc-Gly-ψ[(Z)-CF=CH]-Phe by Pannecoucke and co-workers.
Scheme 8
Scheme 8
Ring-closure metathesis to prepare Gly-ψ[(E)-CF=CH]-Phg by Couve-Bonnaire and co-workers.
Scheme 9
Scheme 9
Stereoselective synthesis of Fmoc-Gly-ψ[(Z)-CF=CH]-Phe by Dory and co-workers.
Scheme 10
Scheme 10
Diastereoselective addition of Grignard reagents to sulfinylamines derived from α-fluoroenals by Pannecoucke and co-workers.
Scheme 11
Scheme 11
NHC-mediated synthesis of monofluoroalkenes by Otaka and co-workers.
Scheme 12
Scheme 12
Stereoselective synthesis of Boc-Tyr-ψ[(Z)-CF=CH]-Gly by Altman and co-workers.
Scheme 13
Scheme 13
Synthesis of the tripeptide Boc-Asp(OBn)-Pro-ψ[(Z)-CF=CH)-Val-CH2OH by Miller and co-workers.
Scheme 14
Scheme 14
Copper-catalyzed synthesis of monofluoralkenes by Taguchi and co-workers.
Scheme 15
Scheme 15
One-pot intramolecular redox reaction to access amide-type isosteres by Otaka and co-workers.
Scheme 16
Scheme 16
Copper-mediated reduction, transmetalation and asymmetric alkylation by Fujii and co-workers.
Scheme 17
Scheme 17
Synthesis of (E)-monofluoroalkene-based dipeptide isostere by Fujii and co-workers.
Scheme 18
Scheme 18
Diastereoselective synthesis of MeOCO-Val-ψ[(Z)-CF=C]-Pro isostere by Chang and co-workers.
Scheme 19
Scheme 19
Asymmetric synthesis of Fmoc-Ala-ψ[(Z)-CF=C]-Pro by Pannecoucke and co-workers.
Scheme 20
Scheme 20
Synthesis of Fmoc-Val-ψ[(E)-CF=C]-Pro by Pannecoucke and co-workers.
Figure 4
Figure 4
BMS-790052 and its fluorinated analogue.
Figure 5
Figure 5
Bioactivities of pentapeptide analogues based on the relative maximum agonistic activity at 10 nM of the compound to 1 μM kisspeptin-10 (%). 100% = maximum agonistic activity at 1 μm kisspeptin-10.
Figure 6
Figure 6
Structures and affinities of the Leu-enkephalin and its fluorinated analogue. The affinity towards DOPr was measured by competitive binding assays.
Figure 7
Figure 7
Activation of the opioid receptor DOPr by Leu-enkephaline and a fluorinated analogue.

Similar articles

Cited by

References

    1. Newman D J, Cragg G M. J Nat Prod. 2012;75:311–335. doi: 10.1021/np200906s. - DOI - PMC - PubMed
    1. Craik D J, Fairlie D P, Liras S, Price D. Chem Biol Drug Des. 2013;81:136–147. doi: 10.1111/cbdd.12055. - DOI - PubMed
    1. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Drug Discovery Today. 2010;15:40–56. doi: 10.1016/j.drudis.2009.10.009. - DOI - PubMed
    1. Choudhary A, Raines R T. ChemBioChem. 2011;12:1801–1807. doi: 10.1002/cbic.201100272. - DOI - PMC - PubMed
    1. Taguchi T, Yanai H. Fluorinated Moieties for Replacement of Amide and Peptide Bonds. In: Ojima I, editor. Fluorine in Medicinal Chemistry and Chemical Biology. Blackwell Publishing Inc.; 2009. pp. 257–290. - DOI

LinkOut - more resources